Coexpression cluster:C238
From FANTOM5_SSTAR
Full id: C238_stomach_gall_breast_duodenum_temporal_MCF7_smallcell
Phase1 CAGE Peaks
Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data
p.value | FDR | nGenes | nPathway | Name |
---|---|---|---|---|
2.15061658683972e-05 | 0.0136134029946954 | 3 | 74 | Gastric acid secretion (KEGG):04971 |
Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data
GO ID | GO name | FDR corrected p-value |
---|---|---|
GO:0007586 | digestion | 2.18722116394922e-11 |
GO:0008900 | hydrogen:potassium-exchanging ATPase activity | 0.000185745920106365 |
GO:0030955 | potassium ion binding | 0.00798746707397297 |
GO:0032501 | multicellular organismal process | 0.00798746707397297 |
GO:0004194 | pepsin A activity | 0.00798746707397297 |
GO:0031420 | alkali metal ion binding | 0.0172023480666984 |
GO:0006813 | potassium ion transport | 0.0175242682012079 |
GO:0022890 | inorganic cation transmembrane transporter activity | 0.0175242682012079 |
GO:0030001 | metal ion transport | 0.0175242682012079 |
GO:0031768 | ghrelin receptor binding | 0.0175242682012079 |
GO:0043400 | cortisol secretion | 0.0175242682012079 |
GO:0004193 | cathepsin E activity | 0.0175242682012079 |
GO:0043062 | extracellular structure organization and biogenesis | 0.0175242682012079 |
GO:0004190 | aspartic-type endopeptidase activity | 0.0175242682012079 |
GO:0006812 | cation transport | 0.0175242682012079 |
GO:0043206 | fibril organization and biogenesis | 0.0175242682012079 |
GO:0051962 | positive regulation of nervous system development | 0.0175242682012079 |
GO:0051965 | positive regulation of synaptogenesis | 0.0175242682012079 |
GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II | 0.0175242682012079 |
GO:0002495 | antigen processing and presentation of peptide antigen via MHC class II | 0.0175242682012079 |
GO:0046676 | negative regulation of insulin secretion | 0.0175242682012079 |
GO:0060079 | regulation of excitatory postsynaptic membrane potential | 0.0175242682012079 |
GO:0002478 | antigen processing and presentation of exogenous peptide antigen | 0.0175242682012079 |
GO:0051960 | regulation of nervous system development | 0.0175242682012079 |
GO:0032024 | positive regulation of insulin secretion | 0.0175242682012079 |
GO:0008324 | cation transmembrane transporter activity | 0.0175242682012079 |
GO:0006824 | cobalt ion transport | 0.0175242682012079 |
GO:0015087 | cobalt ion transmembrane transporter activity | 0.0175242682012079 |
GO:0032692 | negative regulation of interleukin-1 production | 0.0175242682012079 |
GO:0032100 | positive regulation of appetite | 0.0175242682012079 |
GO:0032106 | positive regulation of response to extracellular stimulus | 0.0175242682012079 |
GO:0032103 | positive regulation of response to external stimulus | 0.0175242682012079 |
GO:0045409 | negative regulation of interleukin-6 biosynthetic process | 0.0175242682012079 |
GO:0032691 | negative regulation of interleukin-1 beta production | 0.0175242682012079 |
GO:0032651 | regulation of interleukin-1 beta production | 0.0175242682012079 |
GO:0046697 | decidualization | 0.0175242682012079 |
GO:0032109 | positive regulation of response to nutrient levels | 0.0175242682012079 |
GO:0051963 | regulation of synaptogenesis | 0.0175242682012079 |
GO:0032097 | positive regulation of response to food | 0.0175242682012079 |
GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process | 0.0175242682012079 |
GO:0019884 | antigen processing and presentation of exogenous antigen | 0.0212359104271811 |
GO:0032652 | regulation of interleukin-1 production | 0.0212359104271811 |
GO:0030252 | growth hormone secretion | 0.0212359104271811 |
GO:0060078 | regulation of postsynaptic membrane potential | 0.0212359104271811 |
GO:0015992 | proton transport | 0.0220314283676892 |
GO:0006818 | hydrogen transport | 0.0220314283676892 |
GO:0032098 | regulation of appetite | 0.0220314283676892 |
GO:0032104 | regulation of response to extracellular stimulus | 0.0220314283676892 |
GO:0032107 | regulation of response to nutrient levels | 0.0220314283676892 |
GO:0016608 | growth hormone-releasing hormone activity | 0.0220314283676892 |
GO:0015889 | cobalamin transport | 0.0220314283676892 |
GO:0032611 | interleukin-1 beta production | 0.0220314283676892 |
GO:0032095 | regulation of response to food | 0.0220314283676892 |
GO:0015662 | ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism | 0.0228342053856048 |
GO:0015672 | monovalent inorganic cation transport | 0.0228399978510679 |
GO:0030296 | protein tyrosine kinase activator activity | 0.0241522021383811 |
GO:0008343 | adult feeding behavior | 0.0241522021383811 |
GO:0032612 | interleukin-1 production | 0.0241522021383811 |
GO:0048584 | positive regulation of response to stimulus | 0.0267846915128793 |
GO:0032094 | response to food | 0.0267846915128793 |
GO:0032101 | regulation of response to external stimulus | 0.0267846915128793 |
GO:0006952 | defense response | 0.0268938422781071 |
GO:0050796 | regulation of insulin secretion | 0.0287197098478608 |
GO:0042534 | regulation of tumor necrosis factor biosynthetic process | 0.0287197098478608 |
GO:0042533 | tumor necrosis factor biosynthetic process | 0.0287197098478608 |
GO:0031348 | negative regulation of defense response | 0.0304285892654746 |
GO:0031419 | cobalamin binding | 0.0304285892654746 |
GO:0051899 | membrane depolarization | 0.0304285892654746 |
GO:0050728 | negative regulation of inflammatory response | 0.0304285892654746 |
GO:0015075 | ion transmembrane transporter activity | 0.0319485041327731 |
GO:0045408 | regulation of interleukin-6 biosynthetic process | 0.0319485041327731 |
GO:0001818 | negative regulation of cytokine production | 0.0319485041327731 |
GO:0009755 | hormone-mediated signaling | 0.0319485041327731 |
GO:0015078 | hydrogen ion transmembrane transporter activity | 0.0320987977032904 |
GO:0042625 | ATPase activity, coupled to transmembrane movement of ions | 0.032727017974858 |
GO:0030197 | extracellular matrix constituent, lubricant activity | 0.032727017974858 |
GO:0046888 | negative regulation of hormone secretion | 0.032727017974858 |
GO:0043205 | fibril | 0.032727017974858 |
GO:0006811 | ion transport | 0.032727017974858 |
GO:0015077 | monovalent inorganic cation transmembrane transporter activity | 0.0329083200346653 |
GO:0001937 | negative regulation of endothelial cell proliferation | 0.0329083200346653 |
GO:0040018 | positive regulation of multicellular organism growth | 0.0329083200346653 |
GO:0016358 | dendrite development | 0.0329083200346653 |
GO:0030295 | protein kinase activator activity | 0.0329083200346653 |
GO:0042226 | interleukin-6 biosynthetic process | 0.0329083200346653 |
GO:0032640 | tumor necrosis factor production | 0.0352268091308551 |
GO:0032635 | interleukin-6 production | 0.0397015116088441 |
GO:0030073 | insulin secretion | 0.0397015116088441 |
GO:0008083 | growth factor activity | 0.0407986436183481 |
GO:0051180 | vitamin transport | 0.0407986436183481 |
GO:0042036 | negative regulation of cytokine biosynthetic process | 0.0407986436183481 |
GO:0022891 | substrate-specific transmembrane transporter activity | 0.0407986436183481 |
GO:0016525 | negative regulation of angiogenesis | 0.0407986436183481 |
GO:0001936 | regulation of endothelial cell proliferation | 0.0407986436183481 |
GO:0051048 | negative regulation of secretion | 0.0407986436183481 |
GO:0004806 | triacylglycerol lipase activity | 0.0407986436183481 |
GO:0005391 | sodium:potassium-exchanging ATPase activity | 0.0407986436183481 |
GO:0004175 | endopeptidase activity | 0.0409325213519086 |
GO:0006641 | triacylglycerol metabolic process | 0.0409325213519086 |
GO:0050897 | cobalt ion binding | 0.0409325213519086 |
GO:0019209 | kinase activator activity | 0.0409325213519086 |
GO:0015459 | potassium channel regulator activity | 0.0409325213519086 |
GO:0042626 | ATPase activity, coupled to transmembrane movement of substances | 0.0409325213519086 |
GO:0043492 | ATPase activity, coupled to movement of substances | 0.0409325213519086 |
GO:0002790 | peptide secretion | 0.0409325213519086 |
GO:0046883 | regulation of hormone secretion | 0.0409325213519086 |
GO:0001935 | endothelial cell proliferation | 0.0409325213519086 |
GO:0030072 | peptide hormone secretion | 0.0409325213519086 |
GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances | 0.0415786889852224 |
GO:0022857 | transmembrane transporter activity | 0.0439951814301084 |
GO:0040014 | regulation of multicellular organism growth | 0.0439951814301084 |
GO:0045927 | positive regulation of growth | 0.044202531091155 |
GO:0016338 | calcium-independent cell-cell adhesion | 0.044202531091155 |
GO:0043627 | response to estrogen stimulus | 0.044202531091155 |
GO:0015399 | primary active transmembrane transporter activity | 0.044202531091155 |
GO:0015405 | P-P-bond-hydrolysis-driven transmembrane transporter activity | 0.044202531091155 |
GO:0006638 | neutral lipid metabolic process | 0.0453027747526112 |
GO:0006639 | acylglycerol metabolic process | 0.0453027747526112 |
GO:0040013 | negative regulation of locomotion | 0.0460882211474788 |
GO:0046486 | glycerolipid metabolic process | 0.0460882211474788 |
GO:0035264 | multicellular organism growth | 0.0460882211474788 |
GO:0044421 | extracellular region part | 0.0460912670108073 |
GO:0031347 | regulation of defense response | 0.0460912670108073 |
GO:0050727 | regulation of inflammatory response | 0.0460912670108073 |
GO:0007416 | synaptogenesis | 0.0460912670108073 |
GO:0006662 | glycerol ether metabolic process | 0.0460912670108073 |
GO:0030534 | adult behavior | 0.049201892712604 |
GO:0022892 | substrate-specific transporter activity | 0.049201892712604 |
Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br><br>uberon_data<br>disease_data<br>
Ontology term | p-value | n |
---|---|---|
corpus callosum | 4.10e-23 | 1 |
central nervous system cell part cluster | 4.10e-23 | 1 |
axon tract | 4.10e-23 | 1 |
intercerebral commissure | 4.10e-23 | 1 |
dorsal telencephalic commissure | 4.10e-23 | 1 |
brain white matter | 4.10e-23 | 1 |
brain commissure | 4.10e-23 | 1 |
white matter | 4.10e-23 | 1 |
nervous system commissure | 4.10e-23 | 1 |
cerebral hemisphere white matter | 4.10e-23 | 1 |
small intestine | 1.62e-18 | 4 |
multi cell component structure | 2.90e-12 | 2 |
neuron projection bundle | 2.90e-12 | 2 |
duodenum | 9.66e-09 | 2 |
gallbladder | 1.04e-08 | 3 |
gall bladder primordium | 1.04e-08 | 3 |
gastrointestinal system | 2.59e-08 | 25 |
Ontology term | p-value | n |
---|---|---|
signet ring cell adenocarcinoma | 2.59e-12 | 2 |
Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data
Novel motifs
JASPAR motifs
Motifs | -log10(p-value) |
---|---|
{{{tfbs_overrepresentation_jaspar}}} |
ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data
(#promoters = Number of promoters in this coexpression cluster that have ChIP signal of the TF)
TF | #promoters | Enrichment | p-value | q-value |
---|---|---|---|---|
MAFF#23764 | 5 | 4.85477211120217 | 0.00369832063213046 | 0.0186566636960379 |
Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data